The brief
Founded in response to the failure of current drug development methods, which often overlook the important role of drug-microbiome interactions in individual health outcomes, BioCorteX is currently developing its key product, CarbonMirrorâ„¢.
Having achieved seed funding, BioCorteX required support in defining its market positioning and messaging alongside updated visual brand elements to sustain its current growth.
Utilising these updated brand assets, BioCorteX also desired a new website to act as an information hub for new investors and external stakeholders.